Jan22
CKGSB Americas, New York, NY
Jan17
Want to learn about the real life of CKGSB MBA students? Not quite clear about the uniqueness of CKGSB? Faced with some problems when preparing for MBA application? Email us and talk with our current students!
RIGHT IN YOUR CITY
Dec23
CKSGB Americas hosted its “Roundtable Summit on U.S.-China Relations” on December 11th in New York.
New York City, the United States
Dec24
Dr Liu Jing, Professor of Accounting and Finance and Associate Dean of Cheung Kong Graduate School of Business (CKGSB), released the 2019 Q4 findings of the Cheung Kong Investor Sentiment Survey (CKISS).
Beijing, China
Jan08
CKGSB MBA Program and Embassy of Israel in China are going to co-host the “Meet the Counselor” event on January 8th, 2020 from 19:00-21:00 at CKGSB Beijing Campus. Prestigious speakers including Erez Katz Volovelsky, Counselor, Spokesperson, Director of Communication & Public Diplomacy of Embassy of Israel, and Dr. LI Yang, Associate Professor of Marketing of CKGSB, Academic Director for MBA, will gather here to decode the ecosystem of Israel innovation.
CKGSB Beijing Campus
Dec10
Founding Dean Xiang Bing will join 30+ high-ranking government officials, corporate chiefs and entrepreneurs like China's Former Minister of Commerce, President of the US-China Business Council and Former United States Ambassador to Singapore to debate how the global economic, social and technological landscapes will evolve during this time of immense competition and conflict between these two rival superpowers, and establish a framework for rebuilding positive, albeit competitive, dialogue between them.

Click for 30% off.
New York
Nov13
Date: 2019.11.13
Time: 19:30-21:30
Location: Pullman Kuala Lumpur, 4 Jalan Conlay, 50450, Kuala Lumpur
Kuala Lumpur
Nov11
Date: November 11, 2019
Time: 19:30-21:30
Venue: Yotel Singapore, 366 Orchard Road, 238904, Singapore
Orchard
Nov09
Date: November 9th, 2019
Time: 13:00-14:30
Location: Hotel Sofitel Bangkok Sukhumvit, 189 Sukhumvit Road Soi 13-15, Klongtoey Nua Wattana, Bangkok,Thailand 10110
Bangkok, Thailand
Nov04
In a recent shake-up, China rolled out the “4+7” bulk-buying policy in an effort to drive down prices of generic drugs and force local players to become more globally competitive by investing in more R&D. What does China's new healthcare policy mean for established multinational and Chinese pharmaceutical companies? CKGSB Professor of Finance Li Haitao explains.
Beijing, China